A Promising Development in the Treatment of Sickle Cell Disease

Researchers at Howard University and 12 other medical schools or hospitals across the nation have discovered a potential breakthrough in the treatment of sickle cell disease, an affliction that is far more common among African Americans than it is for the population as a whole. Using a drug called hydroxycarbamide on children with sickle cell disease produced significant reductions in pain and inflammation. The study found no significant harmful side effects from the use of the drug with children. The medication has been used on adults with sickle cell disease and with certain cancers.